0001628280-19-004973.txt : 20190429
0001628280-19-004973.hdr.sgml : 20190429
20190429183309
ACCESSION NUMBER: 0001628280-19-004973
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190425
FILED AS OF DATE: 20190429
DATE AS OF CHANGE: 20190429
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: CLARK IAN T
CENTRAL INDEX KEY: 0001336504
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38683
FILM NUMBER: 19777645
MAIL ADDRESS:
STREET 1: SOLAZYME, INC.
STREET 2: 225 GATEWAY BLVD.
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Guardant Health, Inc.
CENTRAL INDEX KEY: 0001576280
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071]
IRS NUMBER: 454139254
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 505 PENOBSCOT DR.
CITY: REDWOOD CITY
STATE: CA
ZIP: 94063
BUSINESS PHONE: 855-698-8887
MAIL ADDRESS:
STREET 1: 505 PENOBSCOT DR.
CITY: REDWOOD CITY
STATE: CA
ZIP: 94063
4
1
wf-form4_155657717448512.xml
FORM 4
X0306
4
2019-04-25
0
0001576280
Guardant Health, Inc.
GH
0001336504
CLARK IAN T
505 PENOBSCOT DRIVE
REDWOOD CITY
CA
94063
1
0
0
0
COMMON STOCK
2019-04-25
4
M
0
538
4.18
A
538
D
COMMON STOCK
2019-04-25
4
S
0
538
65.11
D
0
D
STOCK OPTION (RIGHT TO BUY)
4.18
2019-04-25
4
M
0
538
0
D
2027-11-29
COMMON STOCK
538.0
16140
D
These shares were sold under a pre-arranged sales plan pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended. The shares sold were acquired contemporaneously upon the cashless exercise of stock options at an exercise price of $4.18 per share.
The stock option vests and becomes exercisable in equal monthly installments over 48 months commencing on October 25, 2017.
/s/ Michael Wiley, as attorney-in-fact for Ian Clark
2019-04-29